Peripheral DEXA scans to identify rates of reduced bone mineral density

HIV Treat Bull - 2009 May-Jun;10(5/6): 04

Simon Collins, HIV i-Base

Short and colleagues presented results from using a portable DEXA scanner to identify high rates of reduced bone mineral density and relationship to ARV use in 168 HIV-positive men (median age 45) treated in Brighton.

Both osteopenia and osteoporosis have been reported at alarming rates compared to age- and gender-matched HIV-negative populations, routine bone density assessments, however, are not routinely yet included in patient management. With time, cost and scanner access reported as limiting factors to change this, researchers at Brighton used a donated portable DEXA scanner (cost new ~ £15-20K) and peripheral scans (taking two minutes) as part of a routine outpatient clinic.

Patients were recruited consecutively from May to August 2008 and underwent a forearm portable DEXA and standard DEXA imaging (lumbar spine and femoral neck) within 12 weeks.

Osteopenia at any site by DEXA was found in 100/168 (60%) overall (70% in ARV-naive, 53% in those with <3 years treatment and 58% in the group with > 3 years ARV use. Osteoporosis at any site was found in 22/168 (13%) overall; and at 5%, 11%, 17% by ARV use in the same groups respectively.

ARV exposure/weeks (p=0.03), HIV infection >13 years [OR 2.81 (1.6–5.1) P=0.00] and fracture post infection [OR 3.23 (1.6–6.6) P=0.02] were independently associated with osteoporosis at any site and no alcohol use was protective [OR 0.35]. Peripheral DXA had a 95% sensitivity and 35% specificity to identify osteoporosis at any site, with a negative predictive value of 98%.

Ref: Short CS et al. Evaluation of peripheral dual energy X-ray absorptiometry to detect osteoporosis in an HIV-seropositive male population. HIV Med. 2009 April; 10(Suppl 1):1 (abstract no. O2).

2009-05-10
IB2009-05-04

©2009. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.